What is Neonatal iodine exposure?
Neonatal iodine exposure refers to a condition where a newborn baby is exposed to too much iodine, either before birth (through the mother) or shortly after birth. This excess iodine can temporarily block the baby's thyroid gland from working properly, leading to a condition called hypothyroidism — meaning the thyroid does not produce enough thyroid hormone. Thyroid hormones are essential for a baby's brain development, growth, and metabolism. Common sources of excess iodine include iodine-containing antiseptics (such as povidone-iodine or Betadine) used on the mother's skin during delivery or on the baby's umbilical cord, iodine-based contrast dyes used in medical imaging, and certain medications like amiodarone taken by the mother during pregnancy. Premature babies are especially vulnerable because their thyroid glands are less mature and more sensitive to the effects of excess iodine. The good news is that this condition is usually temporary. Once the source of excess iodine is removed, the baby's thyroid function typically returns to normal on its own. However, in some cases, temporary thyroid hormone replacement therapy may be needed to protect the baby's developing brain. Early detection through newborn screening programs and close monitoring of thyroid function are key to ensuring a good outcome. If left untreated, even temporary hypothyroidism in a newborn can affect brain development, so prompt medical attention is important.
Key symptoms:
Enlarged thyroid gland (goiter) in the newbornSluggishness or decreased activityPoor feeding or difficulty suckingProlonged jaundice (yellowing of the skin)ConstipationLow body temperaturePuffy or swollen faceDry skinHoarse crySlow heart ratePoor weight gainExcessive sleepiness
- Inheritance
- Sporadic
- Usually appears on its own, not inherited from a parent
- Age of Onset
- Neonatal
- Begins at or shortly after birth (first 4 weeks)
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Neonatal iodine exposure.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Neonatal iodine exposure at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Neonatal iodine exposure.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Financial Resources
1 resourcesSource: manufacturer patient-assistance programs (PAP) + copay-card programs · NORD Patient Assistance · HealthWell Foundation + disease-specific foundation grants · links verified by automated cron
ThyroShield
Fleming & Company, Pharmaceuticals
ThyroShield — Contact Fleming & Company, Pharmaceuticals
Travel Grants
No travel grants are currently matched to Neonatal iodine exposure.
Community
No community posts yet. Be the first to share your experience with Neonatal iodine exposure.
Start the conversation →Latest news about Neonatal iodine exposure
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Neonatal iodine exposure.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What was the source of iodine exposure for my baby, and has it been removed?,How severe is my baby's thyroid dysfunction, and does my baby need medication?,How long will my baby need to take thyroid hormone replacement?,How often will my baby need blood tests to check thyroid function?,Could this iodine exposure cause any long-term effects on my baby's brain development?,How will we know when my baby's thyroid has fully recovered?,Are there any signs I should watch for at home that would require urgent medical attention?
Common questions about Neonatal iodine exposure
What is Neonatal iodine exposure?
Neonatal iodine exposure refers to a condition where a newborn baby is exposed to too much iodine, either before birth (through the mother) or shortly after birth. This excess iodine can temporarily block the baby's thyroid gland from working properly, leading to a condition called hypothyroidism — meaning the thyroid does not produce enough thyroid hormone. Thyroid hormones are essential for a baby's brain development, growth, and metabolism. Common sources of excess iodine include iodine-containing antiseptics (such as povidone-iodine or Betadine) used on the mother's skin during delivery o
How is Neonatal iodine exposure inherited?
Neonatal iodine exposure follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Neonatal iodine exposure typically begin?
Typical onset of Neonatal iodine exposure is neonatal. Age of onset can vary across affected individuals.
What treatment and support options exist for Neonatal iodine exposure?
1 patient support program are currently tracked on UniteRare for Neonatal iodine exposure. See the treatments and support programs sections for copay assistance, eligibility, and contact details.
Frequently asked questions about Neonatal iodine exposure
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Neonatal iodine exposure?
Neonatal iodine exposure is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:238688). It is typically inherited as sporadic. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Neonatal iodine exposure page.
How is Neonatal iodine exposure inherited?
Neonatal iodine exposure follows sporadic inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Neonatal iodine exposure?
Approved treatments for Neonatal iodine exposure are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Neonatal iodine exposure?
Active clinical trials for Neonatal iodine exposure are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Neonatal iodine exposure?
Verified Neonatal iodine exposure specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Neonatal iodine exposure page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.